Is asthma a risk factor for COVID-19? Are phenotypes important?
Main Authors: | Xavier Muñoz, Florencia Pilia, Iñigo Ojanguren, Christian Romero-Mesones, María-Jesús Cruz |
---|---|
Format: | Article |
Language: | English |
Published: |
European Respiratory Society
2021-01-01
|
Series: | ERJ Open Research |
Online Access: | http://openres.ersjournals.com/content/7/1/00216-2020.full |
Similar Items
-
Efficacy and safety of once-daily single-inhaler triple therapy in patients with inadequately controlled asthma: the CAPTAIN trial
by: Iñigo Ojanguren, et al.
Published: (2021-03-01) -
Phenotypes In Immunological Occupational Asthma: What You See Is Not What You Get
by: Xavier Muñoz, et al.
Published: (2020-01-01) -
MEDIATION IN TIMES OF COVID-19
by: Carlo Pilia
Published: (2021-04-01) -
Do Low Molecular Weight Agents Cause More Severe Asthma than High Molecular Weight Agents?
by: Olga Meca, et al.
Published: (2016-01-01) -
Clinical and inflammatory characteristics of Asthma-COPD overlap in workers with occupational asthma.
by: Iñigo Ojanguren, et al.
Published: (2018-01-01)